share_log

Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Lowers Price Target to $8

Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Lowers Price Target to $8

Alliance Global Partners維持對Tonix Pharmicals的買入,將
Benzinga ·  2023/08/01 12:17

Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and lowers the price target from $18 to $8.

Alliance Global Partners分析師詹姆斯·莫洛伊維持Tonix Pharmicals(納斯達克股票代碼:TNXP)的買入,並將目標股價從18美元下調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論